scholarly journals Highly Vascular Pelvic Tumor Causing High-Output Heart Failure Because of Massive Arteriovenous Shunting

2003 ◽  
Vol 67 (6) ◽  
pp. 554-555 ◽  
Author(s):  
Kazuyuki Ozaki ◽  
Hirotaka Oda ◽  
Katsuharu Hatada ◽  
Katsuyuki Sakai ◽  
Kazuyoshi Takahashi ◽  
...  
Author(s):  
Yuta Sudo ◽  
Hiroshi Inagaki

Abstract Background Primary plasma cell leukaemia is rarely associated with high-output heart failure, and the underlying mechanism is not well understood. We encountered a rare case of high-output heart failure caused by primary plasma cell leukaemia. Its underlying mechanism was clarified through imaging studies. Case Summary A 49-year-old man with no specific medical history was admitted to our hospital because of heart failure that did not improve with diuretic therapy. His condition was diagnosed as high-output heart failure and primary plasma cell leukaemia after admission. Extensive bone involvement in primary plasma cell leukaemia and arteriovenous shunts in the same lesion were suspected after various imaging studies. The first cycle of chemotherapy with bortezomib, adriamycin, and dexamethasone led to remission of primary plasma cell leukaemia and improved heart failure symptoms. The patient received further chemotherapy in addition to autologous peripheral blood stem cell transplantation and maintenance therapy and had no recurrence of pPCL or heart failure for 1 year to date. Discussion : Primary plasma cell leukaemia can be associated with high-output heart failure, which is caused by arteriovenous shunting at the lesion site with diffuse bone involvement. Imaging studies may lead to the early diagnosis of aetiology and treatment of patients with high-output heart failure associated with primary plasma cell leukaemia.


2020 ◽  
Vol 126 (2) ◽  
pp. 243-257 ◽  
Author(s):  
Simon Tual-Chalot ◽  
Maria Garcia-Collado ◽  
Rachael E. Redgrave ◽  
Esha Singh ◽  
Benjamin Davison ◽  
...  

2002 ◽  
Vol 11 (5) ◽  
pp. 51-52
Author(s):  
S.S. Damjanovic ◽  
A.N. Neskovic ◽  
M.S. Petakov

2012 ◽  
Vol 2012 (jul09 1) ◽  
pp. bcr2012006289-bcr2012006289 ◽  
Author(s):  
M. I. Mascarenhas ◽  
M. Moniz ◽  
S. Ferreira ◽  
A. Goulao ◽  
R. Barroso

2011 ◽  
pp. P2-705-P2-705
Author(s):  
Jennifer J Miranda ◽  
Marc J Laufgraben ◽  
Simonette Soler ◽  
Athena Poppas ◽  
Geetha Gopalakrishnan

Hypertension ◽  
2021 ◽  
Vol 78 (Suppl_1) ◽  
Author(s):  
Mohammed M Uddin ◽  
Tarec Micho Ulbeh ◽  
Tanveer Mir ◽  
Joseph Sebastian ◽  
Qasim Jehangir ◽  
...  

Background: The literature on the etiologies and complications of high-output heart failure (HOHF) is limited. Objective: To study the causes and complications related to HOHF in the United States (US). Methods: Data from the national readmissions database (NRD) sample that constitutes 49.1% of the stratified sample of all hospitals in the United States, representing more than 95% of the national population were analyzed for hospitalizations with primary diagnosis of HOHF for the years 2017-2018. Etiology associated with HOHF were extracted using ICD-10 codes. Results: A total of 2,107 index hospitalizations (mean age 62.2 ± 19.1) with primary diagnosis of HOHF were recorded in the NRD for the years 2017-2018. The most common causes of HOHF include sepsis 204 (9.7%), leukemia 53 (2.5%), arteriovenous fistula 13 (0.6%), liver cirrhosis 155 (7.4%), Hyperthyroidism 133 (6.3%), thalassemia 23 (1.14%), sickle cell disease 71 (3.35%), morbid obesity 188 (8.95%), COPD 406 (19.3%), myeloproliferative disorders 166 (7.87%). Among the HOHF group, major complications include acute ischemic stroke (42 or 2%), acute kidney injury (593 or 28.1%), hypertensive emergency (74 or 3.5%), atrial fibrillation (409 or 19.4%), ventricular tachycardia/fibrillation (77 or 3.7%), and conduction block (81 or 3.8%) and ST-Elevation myocardial infarction (11 or 0.5%). A total of 83 (3.9%) patients had died during the inpatient hospitalization. Out of the remaining 2,024 patients, a significant portion (62 or 3.1%) required readmission within 30 days. Conclusion: HOHF is an under-reported cardiovascular complication associated with non-cardiovascular disorders. HOHF is associated with significant 30-day readmissions and mortality rates. Proper management of the underlying etiology can prevent the development of HOHF and associated complications. Keywords: cirrhosis; hemodynamics; obesity, leukemia, myeloproliferative disorders, ST-Elevation myocardial infarction (STEMI).


2020 ◽  
Vol 72 (5) ◽  
pp. e363
Author(s):  
M. Libby Weaver ◽  
Yadin Bornstein ◽  
Thomas Reifsnyder

Sign in / Sign up

Export Citation Format

Share Document